NB-01 (NeuroBo)

N/A

Report date: 2022/12/27 16:24:12
NME

Base Information

Drug NameNB-01 (NeuroBo)
Drug Alias NameDA-9801NB-01 (NeuroBo)NB-01
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionBeta-nerve growth factor stimulants
TargetsBeta-nerve growth factor
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurobo Pharmaceuticals IncMthera Pharma Co LtdDong-A ST Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A